Better Therapeutics, Inc. (BTTX) Net Income (Loss) Attributable to Parent USD 2020 - 2022

Historical data

Taxonomy & unit
us-gaap: USD
Description
The portion of profit or loss for the period, net of income taxes, which is attributable to the parent.
Summary
Better Therapeutics, Inc. quarterly/annual Net Income (Loss) Attributable to Parent history and growth rate from 2020 to 2022.
  • Better Therapeutics, Inc. Net Income (Loss) Attributable to Parent for the quarter ending September 30, 2023 was -$5.86 M, a 48.6% increase year-over-year.
  • Better Therapeutics, Inc. Net Income (Loss) Attributable to Parent for the twelve months ending September 30, 2023 was -$31.6 M, a 29.7% increase year-over-year.
  • Better Therapeutics, Inc. annual Net Income (Loss) Attributable to Parent for 2022 was -$39.8 M, a 1.43% increase from 2021.
  • Better Therapeutics, Inc. annual Net Income (Loss) Attributable to Parent for 2021 was -$40.3 M, a 532% decline from 2020.
Net Income (Loss) Attributable to Parent, Trailing 12 Months (USD)
Net Income (Loss) Attributable to Parent, Annual (USD)
Net Income (Loss) Attributable to Parent, YoY Annual Growth (%)
Period Value YoY Chg Change % Start Date End Date Report Filed
2022 -$39.8 M +$575 K +1.43% Jan 1, 2022 Dec 31, 2022 10-K 2023-03-30
2021 -$40.3 M -$33.9 M -532% Jan 1, 2021 Dec 31, 2021 10-K 2023-03-30
2020 -$6.39 M Jan 1, 2020 Dec 31, 2020 10-K 2022-03-28
* An asterisk sign (*) next to the value indicates that the value is likely invalid.